vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Donnelley Financial Solutions, Inc. (DFIN). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $172.5M, roughly 1.0× Donnelley Financial Solutions, Inc.). Donnelley Financial Solutions, Inc. runs the higher net margin — 3.6% vs -0.7%, a 4.3% gap on every dollar of revenue. On growth, Donnelley Financial Solutions, Inc. posted the faster year-over-year revenue change (10.4% vs 0.7%). Donnelley Financial Solutions, Inc. produced more free cash flow last quarter ($47.9M vs $21.3M). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -7.9%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Donnelley Financial Solutions (DFIN) is a financial compliance company based in Chicago, Illinois, United States. The company provides software as a service (SaaS) products, software-enabled services (SeS), print, and compliance services related to US Securities and Exchange Commission regulations to companies in capital and investment markets.
AVNS vs DFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $172.5M |
| Net Profit | $-1.3M | $6.2M |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | 8.3% |
| Net Margin | -0.7% | 3.6% |
| Revenue YoY | 0.7% | 10.4% |
| Net Profit YoY | 99.7% | -1.6% |
| EPS (diluted) | $-0.02 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $172.5M | ||
| Q3 25 | $177.8M | $175.3M | ||
| Q2 25 | $175.0M | $218.1M | ||
| Q1 25 | $167.5M | $201.1M | ||
| Q4 24 | $179.6M | $156.3M | ||
| Q3 24 | $170.4M | $179.5M | ||
| Q2 24 | $171.7M | $242.7M | ||
| Q1 24 | $166.1M | $203.4M |
| Q4 25 | $-1.3M | $6.2M | ||
| Q3 25 | $-1.4M | $-40.9M | ||
| Q2 25 | $-76.8M | $36.1M | ||
| Q1 25 | $6.6M | $31.0M | ||
| Q4 24 | $-397.3M | $6.3M | ||
| Q3 24 | $4.3M | $8.7M | ||
| Q2 24 | $1.8M | $44.1M | ||
| Q1 24 | $-900.0K | $33.3M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | 8.3% | ||
| Q3 25 | 0.1% | 16.1% | ||
| Q2 25 | -42.6% | 24.2% | ||
| Q1 25 | 6.1% | 22.8% | ||
| Q4 24 | -233.0% | 6.0% | ||
| Q3 24 | 7.0% | 10.1% | ||
| Q2 24 | 3.7% | 26.6% | ||
| Q1 24 | 2.4% | 21.9% |
| Q4 25 | -0.7% | 3.6% | ||
| Q3 25 | -0.8% | -23.3% | ||
| Q2 25 | -43.9% | 16.6% | ||
| Q1 25 | 3.9% | 15.4% | ||
| Q4 24 | -221.2% | 4.0% | ||
| Q3 24 | 2.5% | 4.8% | ||
| Q2 24 | 1.0% | 18.2% | ||
| Q1 24 | -0.5% | 16.4% |
| Q4 25 | $-0.02 | $0.31 | ||
| Q3 25 | $-0.03 | $-1.49 | ||
| Q2 25 | $-1.66 | $1.28 | ||
| Q1 25 | $0.14 | $1.05 | ||
| Q4 24 | $-8.64 | $0.21 | ||
| Q3 24 | $0.09 | $0.29 | ||
| Q2 24 | $0.04 | $1.47 | ||
| Q1 24 | $-0.02 | $1.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $24.5M |
| Total DebtLower is stronger | $90.3M | $171.3M |
| Stockholders' EquityBook value | $778.2M | $379.2M |
| Total Assets | $1.1B | $800.4M |
| Debt / EquityLower = less leverage | 0.12× | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $24.5M | ||
| Q3 25 | $70.5M | $22.7M | ||
| Q2 25 | $90.3M | $33.8M | ||
| Q1 25 | $97.0M | $16.2M | ||
| Q4 24 | $107.7M | $57.3M | ||
| Q3 24 | $89.0M | $33.6M | ||
| Q2 24 | $92.2M | $35.0M | ||
| Q1 24 | $75.8M | $43.7M |
| Q4 25 | $90.3M | $171.3M | ||
| Q3 25 | $93.4M | $154.7M | ||
| Q2 25 | $95.7M | $190.1M | ||
| Q1 25 | $98.0M | $189.5M | ||
| Q4 24 | $125.3M | $124.7M | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $379.2M | ||
| Q3 25 | $778.0M | $423.1M | ||
| Q2 25 | $776.3M | $432.1M | ||
| Q1 25 | $839.4M | $419.9M | ||
| Q4 24 | $828.5M | $436.1M | ||
| Q3 24 | $1.2B | $444.5M | ||
| Q2 24 | $1.2B | $441.5M | ||
| Q1 24 | $1.2B | $408.9M |
| Q4 25 | $1.1B | $800.4M | ||
| Q3 25 | $1.1B | $816.3M | ||
| Q2 25 | $1.0B | $874.7M | ||
| Q1 25 | $1.1B | $852.8M | ||
| Q4 24 | $1.2B | $841.6M | ||
| Q3 24 | $1.7B | $843.6M | ||
| Q2 24 | $1.7B | $882.9M | ||
| Q1 24 | $1.7B | $867.8M |
| Q4 25 | 0.12× | 0.45× | ||
| Q3 25 | 0.12× | 0.37× | ||
| Q2 25 | 0.12× | 0.44× | ||
| Q1 25 | 0.12× | 0.45× | ||
| Q4 24 | 0.15× | 0.29× | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $59.8M |
| Free Cash FlowOCF − Capex | $21.3M | $47.9M |
| FCF MarginFCF / Revenue | 11.8% | 27.8% |
| Capex IntensityCapex / Revenue | 3.8% | 6.9% |
| Cash ConversionOCF / Net Profit | — | 9.65× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $59.8M | ||
| Q3 25 | $14.0M | $74.4M | ||
| Q2 25 | $6.8M | $68.4M | ||
| Q1 25 | $25.7M | $-37.7M | ||
| Q4 24 | $57.9M | $56.4M | ||
| Q3 24 | $23.0M | $86.4M | ||
| Q2 24 | $27.8M | $56.2M | ||
| Q1 24 | $-8.0M | $-27.9M |
| Q4 25 | $21.3M | $47.9M | ||
| Q3 25 | $7.0M | $59.2M | ||
| Q2 25 | $-4.2M | $51.7M | ||
| Q1 25 | $19.0M | $-51.0M | ||
| Q4 24 | $53.1M | $41.3M | ||
| Q3 24 | $20.0M | $67.3M | ||
| Q2 24 | $21.9M | $36.8M | ||
| Q1 24 | $-12.1M | $-40.2M |
| Q4 25 | 11.8% | 27.8% | ||
| Q3 25 | 3.9% | 33.8% | ||
| Q2 25 | -2.4% | 23.7% | ||
| Q1 25 | 11.3% | -25.4% | ||
| Q4 24 | 29.6% | 26.4% | ||
| Q3 24 | 11.7% | 37.5% | ||
| Q2 24 | 12.8% | 15.2% | ||
| Q1 24 | -7.3% | -19.8% |
| Q4 25 | 3.8% | 6.9% | ||
| Q3 25 | 3.9% | 8.7% | ||
| Q2 25 | 6.3% | 7.7% | ||
| Q1 25 | 4.0% | 6.6% | ||
| Q4 24 | 2.7% | 9.7% | ||
| Q3 24 | 1.8% | 10.6% | ||
| Q2 24 | 3.4% | 8.0% | ||
| Q1 24 | 2.5% | 6.0% |
| Q4 25 | — | 9.65× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.89× | ||
| Q1 25 | 3.89× | -1.22× | ||
| Q4 24 | — | 8.95× | ||
| Q3 24 | 5.35× | 9.93× | ||
| Q2 24 | 15.44× | 1.27× | ||
| Q1 24 | — | -0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
DFIN
| Technology Service | $68.0M | 39% |
| Capital Markets Compliance And Communications Management | $61.6M | 36% |
| Investment Companies Software Solutions | $30.9M | 18% |
| Print And Distribution Service | $13.6M | 8% |
